Research Development Of The European Pharmaceutical Industry

Author : Arne Noack
Publisher : GRIN Verlag
Page : 54 pages
File Size : 54,9 Mb
Release : 2007-11
Category : Electronic
ISBN : 9783638726702

Get Book

Research & Development of the European Pharmaceutical Industry by Arne Noack Pdf

Seminar paper from the year 2003 in the subject Business economics - Operations Research, grade: A, Vrije University Brussel (Vesalius College), course: Economics, language: English, abstract: The health of their population has always been a great concern for governments of Post-War Europe. In order to achieve their goals they had to work closely together with the pharmaceutical Industry. With the phenomenon of the aging population the importance of development of new drugs is increasing. The increasingly old population of Europe creates a big market for pharmaceutical companies. The pharmaceutical Industry is a very complex sector with close links to other Industries. The chemical Industry for example is an important supplier for materials needed in the process of creating new drugs. Furthermore is the market for pharmaceuticals characterized by extremely little concentration and a huge variety of products. Globally in 1998, the 300 best-selling products held a share of less than 45% of the worlds market. The top two products held 1.3% of the market each.1 This fact creates a necessity for the companies to research new, so called "Blockbuster drugs" to succeed on this market with a high competition. The data on the various methods of drug discovery is enormous and sophisticated. In this paper the structure of the Research & Development sector of the European pharmaceutical industry will be examined, which is of increasing importance for the success of the individual companies. The specific data on the R & D section will be given a general character. Furthermore it will give a brief overview of the different regions in Europe and their individual differences. In the end, the difficulties and challenges of R & D in the pharmaceutical industry will be described and compared to other pharma markets abroad. [1 Data taken from "Combining discovery with development" by Dr. Peter Eddershaw; World pharmaceutical frontiers 2003/2004 ]

Author : Institute of Medicine,Committee on Technological Innovation in Medicine
Publisher : National Academies Press
Page : 225 pages
File Size : 50,7 Mb
Release : 1991-02-01
Category : Medical
ISBN : 9780309044912

Get Book

The Changing Economics of Medical Technology by Institute of Medicine,Committee on Technological Innovation in Medicine Pdf

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.

Author : José Luis Valverde,G. N. Fracchia
Publisher : IOS Press
Page : 108 pages
File Size : 40,9 Mb
Release : 1999
Category : Drugs
ISBN : 9051995008

Get Book

Focus on Pharmaceutical Research by José Luis Valverde,G. N. Fracchia Pdf

The European Commission's Fifth Framework Programme for Research and Technological Development (1998-2002) has been recently launched. As often the case with new programmes, the time allows for a careful evaluation of the work concluded in the previous programme. This volume, the first in a series on Pharmaceuticals, policy and law, takes stock of the experience gathered in the field of pharmaceutical research in the BIOMED 2 Programme of the EU Fourth Framework Programme(1994-1998) , and attempts an analysis of the needs, opportunities and perspectives in the field from the various points of view of the academia, pharmaceutical industry, regulatory authorities, consumers and patients, including those suffering from rare diseases. The case for a robust system for pharmacovigilance in modern pharmacotherapy and underpinning research is defended.

Author : Anonim
Publisher : Unknown
Page : 112 pages
File Size : 41,5 Mb
Release : 1997
Category : Electronic
ISBN : OCLC:245835131

Get Book

A Prospective Analysis of European Pharmaceutical Research, Development and Innovation by Anonim Pdf

Author : Miriam Mennen
Publisher : GRIN Verlag
Page : 31 pages
File Size : 50,5 Mb
Release : 2010-03-18
Category : Medical
ISBN : 9783640568352

Get Book

International Trade and Finance - Pharmaceutical Industry in Germany by Miriam Mennen Pdf

Essay from the year 2006 in the subject Pharmacology, grade: 71 % - A, University of Sunderland (Faculty of Business and Law), course: International Trade and Finance, language: English, abstract: This paper will firstly analyse the importance of R&D, its global dimension and its future trends. Furthermore, the emphasis by nations put on investment in knowledge will be explained. The second part then outlines the main economic theories concerning innovation and knowledge creation. Finally, Germany and its pharmaceutical industry will be taken as an example to illustrate the dimensions of investment in R&D and its outcomes.

Author : Oliver Gassmann,Gerrit Reepmeyer,Maximilian von Zedtwitz
Publisher : Springer Science & Business Media
Page : 194 pages
File Size : 45,5 Mb
Release : 2008-02-19
Category : Business & Economics
ISBN : 9783540776369

Get Book

Leading Pharmaceutical Innovation by Oliver Gassmann,Gerrit Reepmeyer,Maximilian von Zedtwitz Pdf

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.

Author : Walter A. Garcia-Fontes
Publisher : Springer Science & Business Media
Page : 105 pages
File Size : 43,5 Mb
Release : 2012-01-12
Category : Medical
ISBN : 9788493806279

Get Book

Incentives for Research, Development, and Innovation in Pharmaceuticals by Walter A. Garcia-Fontes Pdf

Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.

Author : Congressional Budget Office
Publisher : Lulu.com
Page : 65 pages
File Size : 53,5 Mb
Release : 2013-06-09
Category : Science
ISBN : 9781304121448

Get Book

Research and Development in the Pharmaceutical Industry (A CBO Study) by Congressional Budget Office Pdf

Perceptions that the pace of new-drug development has slowed and that the pharmaceutical industry is highly profitable have sparked concerns that significant problems loom for future drug development. This Congressional Budget Office (CBO) study-prepared at the request of the Senate Majority Leader-reviews basic facts about the drug industry's recent spending on research and development (R&D) and its output of new drugs. The study also examines issues relating to the costs of R&D, the federal government's role in pharmaceutical research, the performance of the pharmaceutical industry in developing innovative drugs, and the role of expected profits in private firms' decisions about investing in drug R&D. In keeping with CBO's mandate to provide objective, impartial analysis, the study makes no recommendations. David H. Austin prepared this report under the supervision of Joseph Kile and David Moore. Colin Baker provided valuable consultation...

Author : Flemming Ørnskov,Maurice Nelson Graham Dukes
Publisher : Unknown
Page : 222 pages
File Size : 42,6 Mb
Release : 1992
Category : Drugs
ISBN : 1852711914

Get Book

The Pharmaceutical Industry in an Extended Europe by Flemming Ørnskov,Maurice Nelson Graham Dukes Pdf

Author : OECD
Publisher : OECD Publishing
Page : 220 pages
File Size : 48,6 Mb
Release : 2019-11-07
Category : Electronic
ISBN : 9789264807662

Get Book

Health at a Glance 2019 OECD Indicators by OECD Pdf

Health at a Glance compares key indicators for population health and health system performance across OECD members, candidate and partner countries. It highlights how countries differ in terms of the health status and health-seeking behaviour of their citizens; access to and quality of health care; and the resources available for health. Analysis is based on the latest comparable data across 80 indicators, with data coming from official national statistics, unless otherwise stated.

Author : Alfonso Gambardella,Luigi Orsenigo,Fabio Pammolli
Publisher : Unknown
Page : 103 pages
File Size : 45,6 Mb
Release : 2000
Category : Business & Economics
ISBN : 0756726328

Get Book

Global Competitiveness in Pharmaceuticals by Alfonso Gambardella,Luigi Orsenigo,Fabio Pammolli Pdf

Pharmaceuticals is a large, high-growth, globalized, & innovation intensive industry. Pharmaceuticals has long been a stronghold of the European industry, & it still provides by far the largest contribution to the European trade balance in high-technology, R&D intensive sectors. However, it is now a diffused perception that the European pharmaceutical industry is losing ground vis-a-vis the U.S. Against this background, the Report examines the competitive position of the European pharmaceutical companies & industries, & compares them with the pharmaceutical companies & industries in other parts of the world, particularly the U.S. Charts, tables & graphs.

Author : S. A. Mann
Publisher : Unknown
Page : 130 pages
File Size : 40,6 Mb
Release : 1967
Category : Europe
ISBN : UOM:35128000808376

Get Book

European Pharmaceutical Market Report, 1967 by S. A. Mann Pdf

Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Global Health,Committee on Mutual Recognition Agreements and Reliance in the Regulation of Medicines
Publisher : National Academies Press
Page : 169 pages
File Size : 53,7 Mb
Release : 2020-04-25
Category : Medical
ISBN : 9780309498630

Get Book

Regulating Medicines in a Globalized World by National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Global Health,Committee on Mutual Recognition Agreements and Reliance in the Regulation of Medicines Pdf

Globalization is rapidly changing lives and industries around the world. Drug development, authorization, and regulatory supervision have become international endeavors, with most medicines becoming global commodities. Drug companies utilize global supply chains that often include facilities in countries with inconsistent regulations from those of the United States, perform pivotal trials in multiple countries to support registration submissions in various jurisdictions, and subsequently market their medicines throughout most of the world. These companies operate across borders and require individual national regulators to ensure that drugs authorized for use in their countries are safe and effective, and appropriate for their health care system and their population. This process involves significant resources and often duplicative work. It is important to consider how this process can be improved in order to better allocate resources, time, and efforts to improve public health. Regulating Medicines in a Globalized World: The Need for Increased Reliance Among Regulators considers the role of mutual recognition and other reliance activities among regulators in contributing to enhancing public health. This report identifies opportunities for leveraging reliance activities more broadly in order to potentially impact public health globally. Key topics in this report include the job of medicines regulators in today's world, what policy makers need to know about today's regulatory environment, stakeholder views of recognition and reliance, as well as removing impediments and facilitating action for greater recognition and reliance among regulatory authorities.

Author : Lars Schweizer,Theodor Dingermann,Otto Quintus Russe
Publisher : Saint Philip Street Press
Page : 0 pages
File Size : 52,8 Mb
Release : 2020-10-09
Category : Medical
ISBN : 1013277783

Get Book

Advances in Pharma Business Management and Research by Lars Schweizer,Theodor Dingermann,Otto Quintus Russe Pdf

This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master's theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business. This work was published by Saint Philip Street Press pursuant to a Creative Commons license permitting commercial use. All rights not granted by the work's license are retained by the author or authors.

Author : Great Britain: Parliament: House of Commons: Health Committee
Publisher : The Stationery Office
Page : 556 pages
File Size : 55,9 Mb
Release : 2005-04-26
Category : Political Science
ISBN : 0215024575

Get Book

The Influence of the Pharmaceutical Industry by Great Britain: Parliament: House of Commons: Health Committee Pdf

Incorporating HC 1030-i to iii.